Erectile dysfunction in diabetic patients

Journal Medical Libanais

Volumn 52, Issue 4, 2004, Pages 217-219

  Chaiban, Joumana T ^a   Azar, Sami T ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; LOSARTAN; PHOSPHODIESTERASE V INHIBITOR; PRASTERONE; PROSTAGLANDIN E1; ROSUVASTATIN; SILDENAFIL; TADALAFIL; TESTOSTERONE UNDECANOATE; VALSARTAN;

AGE; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG USE; ERECTILE DYSFUNCTION; HORMONE SUBSTITUTION; HUMAN; MALE; PATHOPHYSIOLOGY; PATIENT COUNSELING; PENIS PROSTHESIS; PREVALENCE; REVIEW; TREATMENT OUTCOME;

DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; HUMANS; IMPOTENCE; MALE; PHOSPHODIESTERASE INHIBITORS; SEX COUNSELING;

EID: 24044534162     PISSN: 00239852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Recommendations of the first International Consultation on Erectile Dysfunction. Plymouth, UK: Health Publication Ltd, 2000: 713.
2. NIH Consensus Development Panel on Impotence. JAMA 1999; 270: 83-90.
3. Goldstein I. Male sexual circuitry. Working Group for the Study of Central Mechanisms in Erectile Dysfunction. Sci Am 2000; 283 (2): 70-5.
4. Naya Y, Mizutani Y, Ochiai A et al. Preliminary report of association of chronic diseases and erectile dysfunction in middle-aged men in Japan. Urology 2003; 62: 532-6.
5. Ansong K, Lewis C, Jenkins P et al. Help seeking decisions among men with impotence. Urology 1998; 52: 834-85.
6. De Berardis G, Franciosi M, Belfiglio M et al. Erectile dysfunction and quality of life in Type 2 diabetic patients. Diabetes Care 2002; 25: 284-91.
7. Feldman HA, Goldstein I, Hatzichristou DG et al. Impotence and its medical and psychosocial correlates: Results of Massachusetts Male Aging Study. J Urol 1994; 151: 54-61.
8. Montorsi F, Briganti A, Salonia A et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 2003; 44: 360-5.
9. Simonsen U, Garcia-Sacristan A, Prieto D. Penile arteries and erection. J Vase Res 2002; 39: 283-303.
10. Shiri R, Kaskimaki J, Hakama M et al. Effect of chronic diseases on incidence of erectile dysfunction. Urology 2003; 62: 1097-102.
11. Vinik A, Maser R, Mitchell B et al. Diabetic autonomic neuropathy. Diabetes Care 2003; 26: 1553-79.
12. De Angelis L, Marfella MA, Siniscalchi M et al. Erectile and endothelial dysfunction in Type 2 diabetes: a possible link. Diabetologia 2001; 44: 1155-60.
13. Salonia A, Rigatti P, Montorsi F. Sildenafil in erectile dysfunction: a critical review. Current Medical Research and Opinion 2003; 19 (4): 241-62.
14. Kamalesh M, Ariana A, Matorin R et al. Negative stress echocardiographic study predicts excellent long-term prognosis in patients with erectile dysfunction. Int J Cardiol 2003; 90: 291-5.
15. McCulloch DK, Campbell IW, Wu FC et al. The prevalence of diabetic impotence. Diabetologia 1980; 18: 279-83.
16. Alexopoulo O, Jamart J, Maiter D et al. Erectile dysfunction and lower androgenicity in type 1 diabetic patients. Diabetes Metab 2001; 27: 329-36.
17. Baco C, Hu F, Giovannucci E et al. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care 2002; 25: 1458-63.
18. Penson D, Latini D, Lubeck D et al. Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Diabetes Care 2003; 26: 1093-9.
19. Roose S. Depression: Links with ischemic heart disease and erectile dysfunction. J Clin Psychiatry 2003; 64 (Suppl 10): 26-30.
20. El Sakka. Penile axial rigidity Doppler ultrasonography parameters in patients with erectile dysfunction: Association with Type 1 diabetes. Urology 2003; 62: 525-31.
21. Kalinchenko SY, Kazlov GI, Gontcharov NP et al. Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy. Aging Male 2003; 6 (2): 94-9.
22. Cohan P, Korenman SG. Erectile dysfunction. J Clin Endocrinol Metab 2001; 86 (6): 2391-3.
23. Nangle M, Cotter M, Cameron N. Effects of Rosuvastatin on nitric oxide-dependent function in aorta and corpus cavernosum of diabetic mice. Diabetes 2003; 52: 2396-402.
24. Grimm R, Grandits G, Prineas R et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women (TOMHS). Hypertension 1997; 29: 8-14.
25. Lipson L. Treatment of hypertension in diabetic men: Problems with sexual function. Am J Cardiol 1984; 53: 46A-50A.
26. Khan M, Morgan R, Mikhailidis D. The choice of antihypertensive drugs in patients with erectile dysfunction. Current Medical Research and Opinion 2002; 18 (2): 103-7.
27. Fofari R, Zoppi A, Poletti L. Sexual activity in Hypertensive men treated with Valsartan or Carvedilol: A crossover study. American Journal of Hypertension 2001; 14: 27-31.